Kansikuva näyttelystä Ozempic vs Wegovy — What's the Difference?

Ozempic vs Wegovy — What's the Difference?

Podcast by Inception Point AI

englanti

Terveys & hyvinvointi

Rajoitettu tarjous

3 kuukautta hintaan 7,99 €

Sitten 7,99 € / kuukausiPeru milloin tahansa.

  • Podimon podcastit
  • Lataa offline-käyttöön
Aloita nyt

Lisää Ozempic vs Wegovy — What's the Difference?

Discover why semaglutide exists as two FDA-approved drugs with different purposes and doses. Julia Cartwright unravels the regulatory decisions and dosing science that distinguish Ozempic for diabetes from Wegovy for weight management. Learn what doctors consider when choosing between them and why insurance might make the decision for you. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Kaikki jaksot

4 jaksot

jakson Ozempic vs Wegovy — What's the Difference? - What Your Doctor Is Really Thinking kansikuva

Ozempic vs Wegovy — What's the Difference? - What Your Doctor Is Really Thinking

Julia Cartwright examines what doctors really consider when prescribing Ozempic versus Wegovy—the same semaglutide molecule with different FDA approvals, dosing, and insurance coverage. From BMI thresholds and prior authorizations to off-label use and cost barriers, this episode unpacks the complex medical and bureaucratic factors shaping your prescription in ways you never realized. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 2026 - 25 min
jakson Ozempic vs Wegovy — What's the Difference? - One Molecule, Two Labels kansikuva

Ozempic vs Wegovy — What's the Difference? - One Molecule, Two Labels

Join host Julia Cartwright as she unravels how one molecule—semaglutide—became two FDA-approved drugs with distinct missions. We explore the clinical trials, regulatory decisions, and dosing strategies that split Ozempic (for diabetes) from Wegovy (for weight management), revealing why this distinction matters for patients, coverage, and modern medicine's evolving approach to treating chronic disease. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 2026 - 26 min
Kuuntele rekisteröitymällä
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Kiva sovellus podcastien kuunteluun, ja sisältö on monipuolista ja kiinnostavaa
Todella kiva äppi, helppo käyttää ja paljon podcasteja, joita en tiennyt ennestään.

Valitse tilauksesi

Suosituimmat

Rajoitettu tarjous

Premium

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

3 kuukautta hintaan 7,99 €
Sitten 7,99 € / kuukausi

Aloita nyt

Premium

20 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

30 vrk ilmainen kokeilu
Sitten 9,99 € / kuukausi

Aloita maksutta

Premium

100 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

30 vrk ilmainen kokeilu
Sitten 19,99 € / kuukausi

Aloita maksutta

Vain Podimossa

Suosittuja äänikirjoja

Usein kysytyt kysymykset

Lisää kysymyksiä & vastauksia
Aloita nyt

3 kuukautta hintaan 7,99 €. Sitten 7,99 € / kuukausi. Peru milloin tahansa.